Literature DB >> 23562124

Chemotherapy-induced takotsubo cardiomyopathy.

Sakima A Smith1, Alex J Auseon.   

Abstract

Stress cardiomyopathy, also known as takotsubo cardiomyopathy, is a rapidly reversible form of acute heart failure classically triggered by stressful events. It is associated with a distinctive left ventricular contraction pattern described as apical akinesis/ballooning with hyperdynamic contraction of the basal segments in the absence of obstructive coronary artery disease. The traditional paradigm has expanded to include other causes, in particular chemotherapeutic drugs. The literature increasingly suggests an association between cancer, chemotherapeutic drugs, and stress cardiomyopathy. Chemotherapy-induced takotsubo cardiomyopathy is a relatively new phenomenon, but one that merits detailed attention to the elucidation of possible mechanistic links.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23562124     DOI: 10.1016/j.hfc.2012.12.009

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  17 in total

1.  A Young Man with a Mediastinal Mass and Sudden Cardiac Arrest.

Authors:  Matthew W Vanneman; Karim Fikry; Sadeq A Quraishi; William Schoenfeld
Journal:  Ann Am Thorac Soc       Date:  2015-08

Review 2.  Malignancies and outcome in Takotsubo syndrome: a meta-analysis study on cancer and stress cardiomyopathy.

Authors:  Natale Daniele Brunetti; Nicola Tarantino; Francesca Guastafierro; Luisa De Gennaro; Michele Correale; Thomas Stiermaier; Christian Möller; Matteo Di Biase; Ingo Eitel; Francesco Santoro
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

3.  Chemotherapy induced Takotsubo cardiomyopathy.

Authors:  Sunny Goel; Abhishek Sharma; Aakash Garg; Abhinav Chandra; Vijay Shetty
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 4.  Takotsubo syndrome: an overview of pathophysiology, diagnosis and treatment with emphasis on cancer patients.

Authors:  Isabela Bispo Santos da Silva Costa; Clara Salles Figueiredo; Silvia Moulin Ribeiro Fonseca; Cristina Salvadori Bittar; Carolina Maria Domingues de Carvalho Silva; Stéphanie Itala Rizk; Roberto Kalil Filho; Ludhmila Abrahão Hajjar
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

Review 5.  Cancer as a Risk Factor for Cardiovascular Disease.

Authors:  Dana Elena Giza; Gloria Iliescu; Saamir Hassan; Konstantinos Marmagkiolis; Cezar Iliescu
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

6.  Outcomes of Takotsubo cardiomyopathy in hospitalized cancer patients.

Authors:  Parijat Saurav Joy; Achuta Kumar Guddati; Iuliana Shapira
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-14       Impact factor: 4.553

Review 7.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

8.  Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome.

Authors:  Benjamin P Geisler; Roy A Raad; Diana Esaian; Elad Sharon; David R Schwartz
Journal:  J Immunother Cancer       Date:  2015-02-17       Impact factor: 13.751

9.  A case of Takotsubo cardiomyopathy after chemotherapy.

Authors:  Tamir Malley; Edmund Watson
Journal:  Oxf Med Case Reports       Date:  2016-04-07

10.  The intriguing triangle of cancer, chemotherapy and takotsubo syndrome.

Authors:  John E Madias
Journal:  Oxf Med Case Reports       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.